Therapeutic Strategies for Erectile Dysfunction With Emphasis on Recent Approaches in Nanomedicine

被引:7
作者
Ammar, Hussein O. [1 ]
Tadros, Mina I. [2 ]
Salama, Nahla M. [1 ]
Ghoneim, Amira M. [1 ]
机构
[1] Future Univ Egypt, Fac Pharmaceut Sci & Pharmaceut Ind, Dept Pharmaceut & Pharmaceut Technol, New Cairo 11835, Egypt
[2] Cairo Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo 12613, Egypt
关键词
Drugs; Arteries; Construction; Muscles; Biochemistry; Inhibitors; Plasmas; Erectile dysfunction; nanotechnology; phosphodiesterase; sildenafil; tadalafil; vardenafil; SOLID LIPID NANOPARTICLES; NITRIC-OXIDE SYNTHASE; PHOSPHODIESTERASE; 5; INHIBITOR; TOPICAL ALPROSTADIL CREAM; URINARY-TRACT SYMPTOMS; DRUG-DELIVERY-SYSTEM; STEM-CELL THERAPY; RISK-FACTORS; TRANSDERMAL DELIVERY; SILDENAFIL CITRATE;
D O I
10.1109/TNB.2019.2941550
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This review addressed erectile dysfunction, regarding pathophysiology and therapeutic strategies. The line of treatment includes phosphodiesterase type-5 inhibitors and other types of therapy like topical and stem-cell transplant. Scientific literature was assessed to investigate the impact of nanotechnology on erectile dysfunction therapy. Various nanotechnology approaches were applied, like vesicular systems, lipid-based carriers, nanocrystals, dendrimers, liquid crystalline systems and nanoemulsions. Smart nano-systems can alter the landscape of the modern pharmaceutical industry by re- investigation of pharmaceutically suboptimal but biologically active entities for treatment of erectile dysfunction which were previously considered undeveloped.
引用
收藏
页码:11 / 24
页数:14
相关论文
共 157 条
[91]   Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction [J].
Laties, A ;
Sharlip, I .
JOURNAL OF SEXUAL MEDICINE, 2006, 3 (01) :12-27
[92]   Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats [J].
Lee, Sang Kyu ;
Kim, Yoon ;
Kim, Tae Kon ;
Im, Guang-Jin ;
Lee, Bong-Yong ;
Kim, Dong-Hyun ;
Jin, Changbae ;
Yoo, Hye Hyun .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2009, 49 (02) :513-518
[93]   Avanafil, a new rapid-onset phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction [J].
Limin, Ma ;
Johnsen, Niels ;
Hellstrom, Wayne J. G. .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2010, 19 (11) :1427-1437
[94]   Expression, distribution and regulation of phosphodiesterase 5 [J].
Lin, Ching-Shwun ;
Lin, Guiting ;
Xin, Zhong-Cheng ;
Lue, Tom F. .
CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (27) :3439-3457
[95]   Stem Cell Therapy for Erectile Dysfunction: A Critical Review [J].
Lin, Ching-Shwun ;
Xin, Zhong-Cheng ;
Wang, Zhong ;
Deng, Chunhua ;
Huang, Yun-Ching ;
Lin, Guiting ;
Lue, Tom F. .
STEM CELLS AND DEVELOPMENT, 2012, 21 (03) :343-351
[96]   Nanoparticle Improved Stem Cell Therapy for Erectile Dysfunction in a Rat Model of Cavernous Nerve Injury [J].
Lin, Haocheng ;
Dhanani, Nadeem ;
Tseng, Hubert ;
Souza, Glauco R. ;
Wang, Grace ;
Cao, Yanna ;
Ko, Tien C. ;
Jiang, Hui ;
Wang, Run .
JOURNAL OF UROLOGY, 2016, 195 (03) :788-795
[97]   Quantitative evaluation of the effect of poly(amidoamine) dendrimers on the porosity of epithelial monolayers [J].
Lin, Yen-Ling ;
Khanafer, Khalil ;
El-Sayed, Mohamed E. H. .
NANOSCALE, 2010, 2 (05) :755-762
[98]   Evaluation of the Effect of Different Doses of Low Energy Shock Wave Therapy on the Erectile Function of Streptozotocin (STZ)-Induced Diabetic Rats [J].
Liu, Jing ;
Zhou, Feng ;
Li, Guang-Yong ;
Wang, Lin ;
Li, Hui-Xi ;
Bai, Guang-Yi ;
Guan, Rui-Li ;
Xu, Yong-De ;
Gao, Ze-Zhu ;
Tian, Wen-Jie ;
Xin, Zhong-Cheng .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (05) :10661-10673
[99]   The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function [J].
Maas, R ;
Schwedhelm, E ;
Albsmeier, J ;
Böger, RH .
VASCULAR MEDICINE, 2002, 7 (03) :213-225
[100]   Solid lipid nanoparticles -: Production, characterization and applications [J].
Mehnert, W ;
Mäder, K .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 47 (2-3) :165-196